Immunoglobulin G4: an odd antibody
Tóm tắt
Despite its well‐known association with IgE‐mediated allergy, IgG4 antibodies still have several poorly understood characteristics. IgG4 is a very dynamic antibody: the antibody is involved in a continuous process of half‐molecules (i.e. a heavy and attached light‐chain) exchange. This process, also referred to as ‘Fab‐arm exchange’, results usually in asymmetric antibodies with two different antigen‐combining sites. While these antibodies are hetero‐ bivalent, they will behave as monovalent antibodies in most situations. Another aspect of IgG4, still poorly understood, is its tendency to mimic IgG rheumatoid factor (RF) activity by interacting with IgG on a solid support. In contrast to conventional RF, which binds via its variable domains, the activity of IgG4 is located in its constant domains. This is potentially a source of false positives in IgG4 antibody assay results. Because regulation of IgG4 production is dependent on help by T‐helper type 2 (Th2) cells, the IgG4 response is largely restricted to non‐microbial antigens. This Th2‐dependency associates the IgG4 and IgE responses. Another typical feature in the immune regulation of IgG4 is its tendency to appear only after prolonged immunization. In the context of IgE‐mediated allergy, the appearance of IgG4 antibodies is usually associated with a decrease in symptoms. This is likely to be due, at least in part, to an allergen‐blocking effect at the mast cell level and/or at the level of the antigen‐presenting cell (preventing IgE‐facilitated activation of T cells). In addition, the favourable association reflects the enhanced production of IL‐10 and other anti‐inflammatory cytokines, which drive the production of IgG4. While in general, IgG4 is being associated with non‐activating characteristics, in some situations IgG4 antibodies have an association with pathology. Two striking examples are pemphigoid diseases and sclerosing diseases such as autoimmune pancreatitis. The mechanistic basis for the association of IgG4 with these diseases is still enigmatic. However, the association with sclerosing diseases may reflect an excessive production of anti‐inflammatory cytokines triggering an overwhelming expansion of IgG4‐producing plasma cells. The bottom line for allergy diagnosis: IgG4 by itself is unlikely to be a cause of allergic symptoms. In general, the presence of allergen‐specific IgG4 indicates that anti‐inflammatory, tolerance‐inducing mechanisms have been activated. The existence of the IgG4 subclass, its up‐regulation by anti‐inflammatory factors and its own anti‐inflammatory characteristics may help the immune system to dampen inappropriate inflammatory reactions.
Từ khóa
Tài liệu tham khảo
Van der Zee JS, 1986, Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency, J Immunol, 137, 3566, 10.4049/jimmunol.137.11.3566
Schuurman J, 1997, Mouse/human chimeric IgG1 and IgG4 antibodies directed to the house dust mite allergen Der p 2, use in quantification of allergen specific IgG, 27, 1095
Schuurman J, 1999, Normal human immunoglobulin G4 is bispecific, it has two different antigen-combining sites, 97, 693
Zack DJ, 1995, Localization of an Fc‐binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis, J Immunol, 155, 5057, 10.4049/jimmunol.155.10.5057
Jabara HH, 1993, Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL‐4 and hydrocortisone, J Immunol, 151, 4528, 10.4049/jimmunol.151.9.4528
Punnonen J, 1993, IL‐10 and viral IL‐10 prevent IL‐4‐induced IgE synthesis by inhibiting the accessory cell function of monocytes, J Immunol, 151, 1280, 10.4049/jimmunol.151.3.1280
Satoguina JS, 2005, T regulatory‐1 cells induce IgG4 production by B cells, role of IL-10, 174, 4718
Platts‐Mills T, 2001, Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen, a population-based cross-sectional study, 357, 752
Akdis M., 2006, Healthy immune response to allergens, T regulatory cells and more, 18, 738
Platts‐Mills TA., 1979, Local production of IgG, IgA and IgE antibodies in grass pollen hay fever, J Immunol, 122, 2218, 10.4049/jimmunol.122.6.2218
Chapman MD, 1978, Measurement of IgG, IgA and IgE antibodies to Dermatophagoides pteronyssinus by antigen‐binding assay, using a partially purified fraction of mite extract (F4P1), Clin Exp Immunol, 34, 126
Kotowicz K, 1993, Human immunoglobulin class and IgG subclass regulation, dual action of interleukin-4, 23, 2250
Fujieda S, 1995, IL‐4 plus CD40 monoclonal antibody induces human B cells gamma subclass‐specific isotype switch, switching to gamma 1, gamma 3, and gamma 4, but not gamma 2, 155, 2318
Aalberse RC, 1983, Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4‐restricted response, J Immunol, 130, 722, 10.4049/jimmunol.130.2.722
Hussain R, 1992, Control of allergic reactivity in human filariasis, predominant localization of blocking antibody to the IgG4 subclass, 148, 2731
Yazdanbakhsh M, 2001, Th2 responses without atopy, immunoregulation in chronic helminth infections and reduced allergic disease, 22, 372
Wouters D, 2007, Human antichimeric antibodies to infliximab and infusion‐related allergic reactions in patients with rheumatoid arthritis, Allergy Clin Immunol Int, 198
Stapel SO, 2008, Testing for IgG4 against foods is not recommended as a diagnostic tool, EAACI task force report, 63, 793
Lessof MH, 1978, Effects of passive antibody in bee venom anaphylaxis, Johns Hopkins Med J, 142, 1
Aalberse RC, 1983, Clinical reviews in allergy, 289
Neild GH, 2006, Hyper‐IgG4 disease, report and characterisation of a new disease, 4, 23
Malbec O, 1998, Fc epsilon receptor I‐associated lyn‐dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation, J Immunol, 160, 1647, 10.4049/jimmunol.160.4.1647
Schuurman J, 1998, Complementation of Der P 2‐induced histamine release from human basophils sensitized with monoclonal IgE, not only by IgE, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2, 101, 404
Mudde GC, 1990, IgE, an immunoglobulin specialized in antigen capture, 11, 440
Van der Heijden FL, 1993, Serum‐IgE‐facilitated allergen presentation in atopic disease, J Immunol, 150, 3643, 10.4049/jimmunol.150.8.3643